According to filings with the U.S. Securities and Exchange Commission, Nalu Bio is raising $12,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Caitlyn Krebs played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Nalu Bio
Nalu Bio is the leading innovator in the discovery and production of next generation cannabinoid ingredients. Designing pure + safe ingredients. Driven by consumers and backed by science and data, not hype. Nalu is developing high-quality, consistent, cost effective, ingredients for wellness and therapeutics. Our goal is to create safe, effective and predictably performing cannabinoid-derived ingredients that will improve the health and wellness of all those in need by delivering high quality, consistent, scalable, and sustainable ingredients for use in retail and pharmaceutical products. And by expanding the known therapeutic potential of cannabinoids through scientific validation, including well-controlled clinical trials

To learn more about Nalu Bio, visit http://www.nalubio.com/

Contact:
Caitlyn Krebs, Chief Executive Officer
415-706-0623

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.